These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8686719

  • 1. Prospective and serial study of primary amyloidosis with serum amyloid P component scintigraphy: from diagnosis to prognosis.
    Hachulla E, Maulin L, Deveaux M, Facon T, Blétry O, Vanhille P, Wechsler B, Godeau P, Levesque H, Hatron PY, Huglo D, Devulder B, Marchandise X.
    Am J Med; 1996 Jul; 101(1):77-87. PubMed ID: 8686719
    [Abstract] [Full Text] [Related]

  • 2. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL, Hazenberg BP, Franssen EJ, Limburg PC, van Rijswijk MH, Piers DA.
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [Abstract] [Full Text] [Related]

  • 3. Iodine-123-labelled serum amyloid P component scintigraphy in amyloidosis.
    Saïle R, Deveaux M, Hachulla E, Descamps J, Duquesnoy B, Marchandise X.
    Eur J Nucl Med; 1993 Feb; 20(2):130-7. PubMed ID: 8440269
    [Abstract] [Full Text] [Related]

  • 4. 'Localized amyloidosis': 123I-labelled SAP component scintigraphy and labial salivary gland biopsy.
    Maulin L, Hachulla E, Deveaux M, Janin A, Wechsler B, Godeau P, Rousset H, Barrier JH, Hatron PY, Devulder B, Huglo D, Marchandise X.
    QJM; 1997 Jan; 90(1):45-50. PubMed ID: 9093588
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP, van Rijswijk MH, Piers DA, Lub-de Hooge MN, Vellenga E, Haagsma EB, Hawkins PN, Jager PL.
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component.
    Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE, Pugh CW, Winearls CG, Oliver DO, Pepys MB.
    Lancet; 1991 Aug 10; 338(8763):335-9. PubMed ID: 1677697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Scintigraphic quantification and serial monitoring of human visceral amyloid deposits provide evidence for turnover and regression.
    Hawkins PN, Richardson S, MacSweeney JE, King AD, Vigushin DM, Lavender JP, Pepys MB.
    Q J Med; 1993 Jun 10; 86(6):365-74. PubMed ID: 8171184
    [Abstract] [Full Text] [Related]

  • 15. [Scintigraphy of iodine 123 labelled serum amyloid P component in beta 2-microglobulin amyloidosis of hemodialysis].
    Flipo RM, Deveaux M, Duneton O, Foissac-Gegoux P, Dumont A, Duquesnoy B, Marchandise X.
    Nephrologie; 1995 Jun 10; 16(6):419-25. PubMed ID: 8524449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic radionuclide imaging of amyloid: biological targeting by circulating human serum amyloid P component.
    Hawkins PN, Myers MJ, Lavender JP, Pepys MB.
    Lancet; 1988 Jun 25; 1(8600):1413-8. PubMed ID: 2898580
    [Abstract] [Full Text] [Related]

  • 19. Diagnosis and monitoring of amyloidosis.
    Hawkins PN.
    Baillieres Clin Rheumatol; 1994 Aug 25; 8(3):635-59. PubMed ID: 7954867
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.